Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results.
Alessandro VinciguerraAndrea RampiMona-Rita YacoubMoreno TresoldiUmberto TanziniMario BussiMatteo TrimarchiPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2022)
/L, an empirical approach with short-term corticosteroid therapy should be considered to debulk the blood from eosinophils and prevent potential organ involvement.